Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Rubin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Oncology Reports|March 20, 2001
Virtual colonoscopy: a novel imaging modality for colorectal cancerD T Rubin, A H Dachman
European Journal of Gastroenterology & Hepatology|August 25, 2000
Smoking and inflammatory bowel diseaseD T Rubin, S B Hanauer
Alimentary Pharmacology & Therapeutics|January 25, 2011
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysisG R Lichtenstein, D Ramsey, D T Rubin
Alimentary Pharmacology & Therapeutics|April 21, 2018
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' replyB Christensen, P R Gibson, D T Rubin
Current Gastroenterology Reports|September 22, 2000
Malabsorption testing: a reviewP M Ginsburg, P Janefalkar, D T Rubin, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 13, 2001
Effects of billing and documentation requirements on the quantity and quality of teaching by attending physiciansJ F McConville, D T Rubin, H Humphrey, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2014
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's diseaseD T Rubin, R Mody, K L Davis, et al.
Expert Opinion on Pharmacotherapy|May 5, 2001
Treatment of anal fissures with topical nitroglycerinE D Ehrenpreis, D T Rubin, P M Ginsburg, et al.
Alimentary Pharmacology & Therapeutics|October 24, 2008
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flaresP D R Higgins, D T Rubin, K Kaulback, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2016
Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialB G Feagan, H Patel, J-F Colombel, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Oncology Reports|March 20, 2001
Virtual colonoscopy: a novel imaging modality for colorectal cancerD T Rubin, A H Dachman
European Journal of Gastroenterology & Hepatology|August 25, 2000
Smoking and inflammatory bowel diseaseD T Rubin, S B Hanauer
Alimentary Pharmacology & Therapeutics|January 25, 2011
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysisG R Lichtenstein, D Ramsey, D T Rubin
Alimentary Pharmacology & Therapeutics|April 21, 2018
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' replyB Christensen, P R Gibson, D T Rubin
Current Gastroenterology Reports|September 22, 2000
Malabsorption testing: a reviewP M Ginsburg, P Janefalkar, D T Rubin, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 13, 2001
Effects of billing and documentation requirements on the quantity and quality of teaching by attending physiciansJ F McConville, D T Rubin, H Humphrey, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2014
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's diseaseD T Rubin, R Mody, K L Davis, et al.
Expert Opinion on Pharmacotherapy|May 5, 2001
Treatment of anal fissures with topical nitroglycerinE D Ehrenpreis, D T Rubin, P M Ginsburg, et al.
Alimentary Pharmacology & Therapeutics|October 24, 2008
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flaresP D R Higgins, D T Rubin, K Kaulback, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2016
Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialB G Feagan, H Patel, J-F Colombel, et al.
Pageof 2